RBC
AMGN icon

Ronald Blue & Co’s Amgen AMGN Stock Holding History

Ronald Blue & Co’s Portfolio AMGN Stock Details AMGN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2017
Q2 		$221K Buy
+1,283
New +$209K 0.01% 193
2016
Q4 		– Sell
-1,222
Closed -$204K – 236
2016
Q3 		$204K Sell
1,222
-238
-16% -$40.2K 0.01% 185
2016
Q2 		$222K Sell
1,460
-42
-3% -$6.53K 0.01% 182
2016
Q1 		$225K Buy
+1,502
New +$223K 0.01% 167
2015
Q3 		– Sell
-1,750
Closed -$268K – 306
2015
Q2 		$268K Sell
1,750
-1,965
-53% -$315K 0.01% 272
2015
Q1 		$593K Buy
3,715
+58
+2% +$9.13K 0.03% 144
2014
Q4 		$583K Buy
3,657
+390
+12% +$60.8K 0.03% 145
2014
Q3 		$459K Sell
3,267
-121
-4% -$15.8K 0.03% 168
2014
Q2 		$401K Sell
3,388
-200
-6% -$23.2K 0.03% 189
2014
Q1 		$442K Sell
3,588
-413
-10% -$50.1K 0.03% 169
2013
Q4 		$457K Buy
4,001
+589
+17% +$67K 0.03% 161
2013
Q3 		$382K Buy
3,412
+3,296
+2,841% +$357K 0.03% 163
2013
Q2 		$11K Buy
+116
New +$12K ﹤0.01% 225

Other funds holding AMGN

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Primecap Management
Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
ClearBridge Investments
ClearBridge Investments New York $115B AUM 24.78% 1-Year Est. Return

Ronald Blue & Co's AMGN Position: Q2 2017 in Review

Ronald Blue & Co opened a new position in Amgen (AMGN) in Q2 2017: 1,283 shares worth $221K. The stake represents 0.01% of the portfolio and ranks #193 among its holdings. This is a return to the name: Ronald Blue & Co previously reported a position in AMGN as recently as Q3 2016.

Ronald Blue & Co first reported a position in AMGN in Q2 2013 and has held it in 13 quarters since. The position peaked at $593K in Q1 2015. 1,596 funds tracked by Wall St. Rank hold AMGN as of Q2 2017.

  • Ronald Blue & Co held 1,283 shares of Amgen worth $221K as of Q2 2017.
  • Amgen was a new Ronald Blue & Co position in Q2 2017.
  • Amgen made up 0.01% of Ronald Blue & Co's portfolio in Q2 2017, its #193 holding.
  • Ronald Blue & Co first reported a position in Amgen in Q2 2013 and has held it in 13 quarters since.
  • Ronald Blue & Co's Amgen position peaked at $593K in Q1 2015.
  • 1,596 funds tracked by Wall St. Rank held Amgen as of Q2 2017.

Based on Ronald Blue & Co's 13F filing for Q2 2017, filed 28 Jul 2017.